IDEAYA Biosciences, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IDEAYA Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2019 to Q1 2024.
  • IDEAYA Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $349M, a 11831% increase year-over-year.
  • IDEAYA Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $363M, a 273% increase from 2022.
  • IDEAYA Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $97.2M, a 33.2% decline from 2021.
  • IDEAYA Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $145M, a 13% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $349M +$346M +11831% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $2.93M +$2.27M +348% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $653K -$41.4M -98.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $42M +$42M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $34K* +$860K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 -$826K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.